£520.00

It has never been this cheap. We have no record of a lower price.

£520 today · cheaper than every other day in the last 3 months

Targeted Therapy Liver Cancer Drugs Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 88 days · 88 data points

Historical
Generating forecast…
£520.00 £494.00 £504.40 £514.80 £525.20 £535.60 £546.00 11 August 2026 01 September 2026 23 September 2026 15 October 2026 06 November 2026
View at Amazon ↗

Price data checked 3 days ago

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 88 days • 1 price levels

Days at Price
88 days 0 22 44 66 88 £520 Days at Price

Price Analysis

Most common price: £520 (88 days, 100.0%)

Price range: £520 - £520

Price levels: 1 different prices over 88 days

Description

This comprehensive study provides a detailed outlook for targeted therapy liver cancer drugs in the United States from 2023 to 2028. It offers critical insights into latent demand, also known as potential industry earnings (P.I.E.), across approximately 12,600 cities. By reporting the percent share of each city relative to its state and the entire United States, this report provides comparative benchmarks for quick analysis. These statistics assist professionals in developing effective distribution and sales force strategies. The data covers extensive geographic areas, allowing for a precise understanding of market potential throughout the country.

Key Features

Covers latent demand and potential industry earnings for targeted therapy liver cancer drugs in the United States.

Provides detailed estimates across approximately 12,600 cities throughout the United States.

Includes comparative benchmarks by reporting each city's percent share of its state and the national market.

Supports the development of effective distribution and sales force strategies through statistical data.

Offers a long-term market outlook spanning the years 2023 through 2028.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
11 November 2022

Similar Products You Might Like

Targeted Therapy Liver Cancer Drugs India Outlook 2023-2028
99% match

Targeted Therapy Liver Cancer Drugs India Outlook 2023-2028

£515.00 07 Nov 2026
World Outlook: Targeted Therapy Liver Cancer Drugs 2025-2030
99% match

World Outlook: Targeted Therapy Liver Cancer Drugs 2025-2030

£790.00 02 Nov 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China
99% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in China

£495.00 06 Nov 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in Japan
99% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in Japan

£495.00 05 Nov 2026
US Liver Cancer Drug Outlook 2016-2021 Econometric Study
99% match

US Liver Cancer Drug Outlook 2016-2021 Econometric Study

£595.00 01 Nov 2026
The 2016-2021 Outlook for Liver Cancer Drugs in Japan
98% match

The 2016-2021 Outlook for Liver Cancer Drugs in Japan

£595.00 27 Aug 2026
US Targeted Therapy Liver Cancer Drug Outlook 2023-2028
98% match

US Targeted Therapy Liver Cancer Drug Outlook 2023-2028

£490.00 07 Nov 2026
The 2016 Report on Liver Cancer Drugs: World Market Segmentation by City
98% match

The 2016 Report on Liver Cancer Drugs: World Market Segmentation by City

£995.00 29 Oct 2026
World Outlook for Liver Cancer Therapeutics 2025-2030
98% match

World Outlook for Liver Cancer Therapeutics 2025-2030

Price unavailable
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026
Cancer Supportive Care Drugs Outlook 2023-2028 Report
98% match

Cancer Supportive Care Drugs Outlook 2023-2028 Report

£520.00 06 Nov 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
India Cancer Supportive Care Drugs Outlook 2023-2028
98% match

India Cancer Supportive Care Drugs Outlook 2023-2028

£515.00 06 Nov 2026
US Cancer Supportive Care Outlook 2023-2028 Study Report
98% match

US Cancer Supportive Care Outlook 2023-2028 Study Report

£520.00 07 Nov 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China
98% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China

£595.00 27 Oct 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
98% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£595.00 04 Nov 2026
2023-2028 US Cancer Screening Outlook - Market Study
97% match

2023-2028 US Cancer Screening Outlook - Market Study

£520.00 05 Nov 2026
The 2023-2028 Outlook for Liver Health Supplements in India
97% match

The 2023-2028 Outlook for Liver Health Supplements in India

£515.00 03 Sep 2026
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 02 Nov 2026
The 2023-2028 Outlook for Liver Health Supplements in the United States
97% match

The 2023-2028 Outlook for Liver Health Supplements in the United States

£520.00 03 Sep 2026
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
97% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£520.00 06 Nov 2026
Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study
97% match

Non-Hodgkin Lymphoma Chemotherapy Outlook 2023-2028 Study

£520.00 07 Nov 2026
The 2023-2028 Outlook for Cancer Testing-Screening in the United States
97% match

The 2023-2028 Outlook for Cancer Testing-Screening in the United States

£520.00 30 Sep 2026
World Outlook for Liver Cancer Diagnostics 2025-2030
97% match

World Outlook for Liver Cancer Diagnostics 2025-2030

Price unavailable